All payments made in the preview are in test mode. Read more
Sign in
Back to Atlas
APotentially durableStandard research/education caution
CMP-0142
Not approved for human use

Trenbolone enanthate

Ergogenic / AAS

Longer-acting potent anabolic-androgenic effect

Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type
Esterified 19-nor AAS
Primary mechanism
Trenbolone prodrug; AR agonist; commonly cited A:A ~500:500
Primary market use
Performance misuse

Pharmacology

Molecular weight (Da)
382.54
Oral bioavailability
N/A (injectable ester)
Half-life
~5-7 d release-dependent
Route tags
Route-dependent / verify
Evidence level
Research/gray-market
Clinical status
Not approved for human use
Value-for-money score
4 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Ester changes release; base trenbolone potency/ratio used for primary info.

Educational and organizational assistant matrix. Not medical advice.

BioChrysalis Atlas is an educational, organizational, and tracking asset. It does not provide medical advice, diagnosis, treatment, prescriptions, or individualized dosing instructions. Compound profiles, protocol notes, and dosage fields summarize publicly discussed or source-listed reference patterns and are not recommendations. Consult a qualified healthcare professional before starting, stopping, or modifying any compound, medication, or supplement protocol.

© BioChrysalis · Evolve · Ascend · Transcend